Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

ADPT stock hub

Adaptive Biotechnologies Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ADPTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ADPT

In the news

Latest news · ADPT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-24

P25 -106.6P50 -46.9P75 -3.1

ROIC-6.9

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ADPT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001478320
Company name	Adaptive Biotechnologies Corporation
Country	United States
Country code	US
Cusip	00650F109
Employees	624
Employees Change	5%
Employees Change Percent	0.81
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2019-06-27
Isin	US00650F1093
Last refreshed	2026-05-10
Market cap	$2.2B
Market cap category	Mid-Cap
Price	$13.81
Price currency	USD
Rev Per Employee	473,408.65x
Sector	Healthcare
Sic	2836
Symbol	ADPT
Website	https://www.adaptivebiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.25%
EV Sales Forward	7.23x
EV/Sales	7.38x
FCF yield	-1.34%
P/B ratio	10.19x
P/S ratio	7.48x
PS Forward	7.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-15.82%
EBITDA Margin	-10.08%
Gross margin	43.71%
Gross Profit	$129.1M
Gross Profit Growth	497.6%
Gross Profit Growth Q	153.47%
Net Income	$-49.7M
Net Income Growth Quarters	9%
Net Income Growth Years	2%
Pretax Margin	-16.8%
Profit Margin	-16.82%
Profit Per Employee	$-79,615
ROA	-5.74
Roa5y	-13.29
ROCE	-11.15
ROE	-23.95
Roe5y	-43.39
ROIC	-6.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	56.8%
Cagr3y	29.55%
Cagr5y	-16.97%
EPS Growth Quarters	9
EPS Growth Years	2
Revenue Growth	55.87x
Revenue Growth Q	35.15x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	17.02x
Revenue Growth5 Y	20.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.58
Assets	$505.9M
Cash	$218.3M
Current Assets	$291.8M
Current Liabilities	$87M
Debt	$208.2M
Debt Equity	$0.93
Equity	$224.2M
Interest Coverage	-3.97
Liabilities	$281.7M
Long Term Assets	$214.1M
Long Term Liabilities	$194.7M
Net Cash	$29M
Net Cash By Market Cap	$1.31
Net Cash Growth	135.77%
Net Debt Equity	$-0.13
Tangible Book Value	$96.1M
Tangible Book Value Per Share	$0.6
WACC	15.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.35
Inventory Turnover	16.72
Net Working Capital	$779,000
Quick ratio	3.08
Working Capital	$204.8M
Working Capital Turnover	$1.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.62%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	56.75%
200-day SMA	14.99
3Y total return	117.48%
50-day SMA	14.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-60.53%
All Time High	71.25
All Time High Change	-80.62%
All Time High Date	2021-01-19
All Time Low	2.28
All Time Low Change	505.7%
All Time Low Date	2024-04-19
ATR	0.89
Beta	2.16
Beta1y	1.12
Beta2y	1.32
Ch YTD	-14.96
High	14.46
High52	20.76
High52 Date	2025-11-25
High52ch	-33.48%
Low	13.56
Low52	8.5
Low52 Date	2025-05-23
Low52ch	62.47%
Ma50ch	-2.57%
Premarket Change Percent	0.07
Premarket Price	$14.7
Premarket Volume	276
Price vs 200-day SMA	-7.88%
RSI	46.92
RSI Monthly	54.05
RSI Weekly	46.84
Sharpe ratio	0.96x
Sortino ratio	1.58
Total Return	-3.62%
Tr YTD	-14.96
Tr1m	0.73%
Tr1w	-3.22%
Tr3m	-12.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	1
Analyst Price Target Top	$20
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.16
Earnings Revenue Estimate	61,073,064x
Earnings Revenue Estimate Growth	16.55x
Operating Income	$-46.7M
Operating margin	-15.82
Price target	$19.25
Price Target Change	$39.39
Price Target Change Top	$44.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	125,373,598%
Float Percent	78.34%
Shares Insiders	2.92%
Shares Institutions	79.01%
Shares Out	160,044,392
Shares Qo Q	1.56%
Shares Yo Y	3.62%
Short Float	6.82%
Short Ratio	4.16
Short Shares	5.34

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-80.8M
Average Volume	1,681,699.55x
Bv Per Share	1.35
CAPEX	$-2.5M
Ch1m	0.73
Ch1w	-3.22
Ch1y	56.75
Ch3m	-12.43
Ch3y	117.5
Ch5y	-60.53
Ch6m	-6.63
Change	-5.99%
Change From Open	-4.5
Close	14.69
Days Gap	-1.57
Depreciation Amortization	16,939,000
Dollar Volume	21,020,159.6
Earnings Date	2026-05-05
Earnings Time	amc
EBIT	$-46.7M
EBITDA	$-29.8M
EPS	$-0.32
F Score	5
FCF	$-29.5M
FCF EV Yield	-1.35x
FCF Per Share	$-0.18
Financing CF	32,452,000
Fiscal Year End	December
Founded	2,009
Goodwill	118,972,000
Investing CF	21,520,000
Ipr	-30.95
Iprfo	-64.6
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	15.8
Ma150ch	-12.58%
Ma20	14.2
Ma20ch	-2.77%
Net CF	26,933,000
Next Earnings Date	2026-08-04
Open	14.46
Optionable	Yes
Position In Range	27.78
Ppne	71,022,000
Pre Close	14.69
Price Date	2026-05-08
Ptbv Ratio	23.01
Relative Volume	0.91x
Revenue	295,407,000x
SBC By Revenue	17.35x
Share Based Comp	51,264,000
Tr6m	-6.63%
Us State	Washington
Volume	1,522,097
Z Score	1.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ADPT pay a dividend?

Capital-return profile for this ticker.

Performance

ADPT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ADPT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+79.0%

Float: +78.3% of shares outstanding

Insider ownership

+2.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ADPT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.9

Neutral momentum band

Price vs 200-day MA

-7.9%

50/200-day relationship not available

Beta (5Y)

2.16

More volatile than the market

Sharpe ratio

0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ADPT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ADPT stock rating?

Adaptive Biotechnologies Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ADPT analysis?

The full report lives at /stocks/ADPT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ADPT?

The latest report frames ADPT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ADPT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.